Reputation – Healthcare professionals (HCPs): Overview

Pharmaceutical companies operating in the UK enjoy a strong reputation among HCPs

The pharmaceutical industry in the UK is well known, well regarded and trusted by HCPs. Only health charities and universities conducting R&D attract a higher level of trust in our index.

Familiarity with pharmaceutical companies operating in the UK is high and rising. Eight in ten feel they know at least a fair amount about the sector, up from seven in ten HCPs in November 2021. This high degree of familiarity has not yet led to increased favourability, but it has resulted in a higher level of both advocacy and trust. As of May 2023, these reputation KPIs were at all-time highs in our index.

Over one in three HCPs have a high degree of trust in pharmaceutical companies operating in the UK, but the majority view is still one of neutrality. Very few distrust or are critical of the sector.

As in previous years, HCP’s trust in pharmaceutical companies operating in the UK is often a result of positive personal experiences and interactions with pharma employees such as reps and medical science liaisons (MSLs).

HCPs speak positively about the sector’s research and development activity, as well as its commitment to rigorous ethical, quality, and safety standards. The pandemic also remains a source of positivity; nearly two in three say they feel more positive towards the sector since the outbreak of COVID-19.

Share this chart: https://datawrapper.dwcdn.net/M2jKs/9/

Pharmaceutical companies continue to gain recognition from HCPs for their contributions to medicine discovery, with around nine in ten HCPs agreeing that pharma companies both save and improve lives with their medicines and vaccines.